Download PDF
Semin Respir Crit Care Med 2014; 35(01): 027-040
DOI: 10.1055/s-0033-1363449
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

New Applications of Magnetic Resonance Imaging for Thoracic Oncology

Yoshiharu Ohno
1   Division of Functional and Diagnostic Imaging Research, Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
2   Advanced Biomedical Imaging Research Center, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
30 January 2014 (online)

    Permissions and Reprints

Abstract

Since the clinical introduction of magnetic resonance imaging (MRI), the chest has been one of its most challenging applications, and since the 1980s many physicists and radiologists have been trying to evaluate images for various lung diseases as well as mediastinal and pleural diseases. However, thoracic MRI could not yield image quality sufficient for a convincing diagnosis within an acceptable examination time, so MRI did not find acceptance as a substitute for computed tomography (CT) and other modalities. Until the 2000, thoracic MRI was generally used only for select, minor clinical indications. Within the past decade, however, technical advances in sequencing, scanners and coils, adaptation of parallel imaging techniques, utilization of contrast media, and development of postprocessing tools have been developed. In addition, pulmonary functional MRI has been extensively researched, and MR is being assessed as a new research and diagnostic tool for pulmonary diseases. State-of-the art thoracic MRI now has the potential as a substitute for traditional imaging techniques and/or to play a complimentary role in patient management. In this review, we focus on these advances in MRI for thoracic oncologic imaging, especially for pulmonary nodule assessment, lung cancer staging, mediastinal tumor diagnosis and malignant mesothelioma evaluation, prediction of postoperative lung function, and prediction or evaluation of therapeutic effectiveness. We also discuss the potential and limitations of these advances for routine clinical practice in comparison with other modalities such as CT, positron emission tomography (PET), PET/CT, or nuclear medicine studies.

Keywords

lung - mediastinum - pleura - MRI - CT - oncology

Acknowledgement

This article was partly supported by research grants from The Sagawa Foundation for Promotion of Cancer Research, Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (JSTS.KAKEN; No. 20591442), Philips Healthcare and Toshiba Medical Systems.


 

  • References

  • 1 Henschke CI, McCauley DI, Yankelevitz DF , et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354 (9173): 99-105
    CrossrefPubMedGoogle Scholar
  • 2 Swensen SJ, Jett JR, Hartman TE , et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005; 235 (1) 259-265
    CrossrefPubMedGoogle Scholar
  • 3 Tuddenham WJ. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol 1984; 143 (3) 509-517
    CrossrefPubMedGoogle Scholar
  • 4 Aberle DR, Adams AM, Berg CD , et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365 (5) 395-409
    CrossrefPubMedGoogle Scholar
  • 5 Church TR ; National Lung Screening Trial Executive Committee. Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003; 10 (6) 713-715
    CrossrefPubMedGoogle Scholar
  • 6 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246 (3) 697-722
    CrossrefPubMedGoogle Scholar
  • 7 Patz Jr EF, Lowe VJ, Hoffman JM , et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188 (2) 487-490
    PubMedGoogle Scholar
  • 8 Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993; 104 (4) 997-1002
    CrossrefPubMedGoogle Scholar
  • 9 Croft DR, Trapp J, Kernstine K , et al. FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 2002; 36 (3) 297-301
    CrossrefPubMedGoogle Scholar
  • 10 Chun EJ, Lee HJ, Kang WJ , et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009; 65 (2) 180-186
    CrossrefPubMedGoogle Scholar
  • 11 Sakai F, Sone S, Maruyama A , et al. Thin-rim enhancement in Gd-DTPA-enhanced magnetic resonance images of tuberculoma: a new finding of potential differential diagnostic importance. J Thorac Imaging 1992; 7 (3) 64-69
    CrossrefPubMedGoogle Scholar
  • 12 Sakai F, Sone S, Kiyono K , et al. MR of pulmonary hamartoma: pathologic correlation. J Thorac Imaging 1994; 9 (1) 51-55
    PubMedGoogle Scholar
  • 13 Fujimoto K, Meno S, Nishimura H, Hayabuchi N, Hayashi A. Aspergilloma within cavitary lung cancer: MR imaging findings. AJR Am J Roentgenol 1994; 163 (3) 565-567
    CrossrefPubMedGoogle Scholar
  • 14 Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994; 106 (4) 1156-1161
    CrossrefPubMedGoogle Scholar
  • 15 Chung MH, Lee HG, Kwon SS, Park SH. MR imaging of solitary pulmonary lesion: emphasis on tuberculomas and comparison with tumors. J Magn Reson Imaging 2000; 11 (6) 629-637
    CrossrefPubMedGoogle Scholar
  • 16 Gaeta M, Minutoli F, Ascenti G , et al. MR white lung sign: incidence and significance in pulmonary consolidations. J Comput Assist Tomogr 2001; 25 (6) 890-896
    CrossrefPubMedGoogle Scholar
  • 17 Gaeta M, Vinci S, Minutoli F , et al. CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: pictorial review. Eur Radiol 2002; 12 (1) 181-189
    CrossrefPubMedGoogle Scholar
  • 18 Ohno Y, Sugimura K, Hatabu H. MR imaging of lung cancer. Eur J Radiol 2002; 44 (3) 172-181
    CrossrefPubMedGoogle Scholar
  • 19 Sieren JC, Ohno Y, Koyama H, Sugimura K, McLennan G. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 2010; 32 (6) 1353-1369
    CrossrefPubMedGoogle Scholar
  • 20 Kono M, Adachi S, Kusumoto M, Sakai E. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging 1993; 8 (1) 18-26
    PubMedGoogle Scholar
  • 21 Kusumoto M, Kono M, Adachi S , et al. Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. Invest Radiol 1994; 29 (Suppl. 02) S255-S256
    CrossrefPubMedGoogle Scholar
  • 22 Uto T, Takehara Y, Nakamura Y , et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252 (1) 247-254
    CrossrefPubMedGoogle Scholar
  • 23 Koyama H, Ohno Y, Kono A , et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol 2008; 18 (10) 2120-2131
    CrossrefPubMedGoogle Scholar
  • 24 Mori T, Nomori H, Ikeda K , et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 2008; 3 (4) 358-364
    CrossrefPubMedGoogle Scholar
  • 25 Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?. AJR Am J Roentgenol 2008; 191 (2) 464-470
    CrossrefPubMedGoogle Scholar
  • 26 Cronin P, Dwamena BA, Kelly AM, Carlos RC. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology 2008; 246 (3) 772-782
    CrossrefPubMedGoogle Scholar
  • 27 Acker MR, Burrell SC. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol 2005; 33 (2) 69-74 , quiz 75–77
    PubMedGoogle Scholar
  • 28 Bruzzi JF, Munden RF. PET/CT imaging of lung cancer. J Thorac Imaging 2006; 21 (2) 123-136
    CrossrefPubMedGoogle Scholar
  • 29 Kligerman S, Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT. AJR Am J Roentgenol 2009; 193 (5) 1203-1211
    CrossrefPubMedGoogle Scholar
  • 30 Webb WR, Gatsonis C, Zerhouni EA , et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178 (3) 705-713
    CrossrefPubMedGoogle Scholar
  • 31 White CS. MR evaluation of the pericardium and cardiac malignancies. Magn Reson Imaging Clin N Am 1996; 4 (2) 237-251
    PubMedGoogle Scholar
  • 32 Wong J, Haramati LB, Rozenshtein A, Yanez M, Austin JH. Non-small-cell lung cancer: practice patterns of extrathoracic imaging. Acad Radiol 1999; 6 (4) 211-215
    CrossrefPubMedGoogle Scholar
  • 33 Sakai S, Murayama S, Murakami J, Hashiguchi N, Masuda K. Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr 1997; 21 (4) 595-600
    CrossrefPubMedGoogle Scholar
  • 34 Murata K, Takahashi M, Mori M , et al. Chest wall and mediastinal invasion by lung cancer: evaluation with multisection expiratory dynamic CT. Radiology 1994; 191 (1) 251-255
    PubMedGoogle Scholar
  • 35 Takahashi K, Furuse M, Hanaoka H , et al. Pulmonary vein and left atrial invasion by lung cancer: assessment by breath-hold gadolinium-enhanced three-dimensional MR angiography. J Comput Assist Tomogr 2000; 24 (4) 557-561
    CrossrefPubMedGoogle Scholar
  • 36 Ohno Y, Adachi S, Motoyama A , et al. Multiphase ECG-triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging 2001; 13 (2) 215-224
    CrossrefPubMedGoogle Scholar
  • 37 Boiselle PM, Patz Jr EF, Vining DJ, Weissleder R, Shepard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics 1998; 18 (5) 1061-1069
    PubMedGoogle Scholar
  • 38 Takenaka D, Ohno Y, Hatabu H , et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 2002; 44 (3) 216-224
    CrossrefPubMedGoogle Scholar
  • 39 Gückel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996; 200 (3) 681-686
    PubMedGoogle Scholar
  • 40 Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 2002; 224 (2) 503-511
    CrossrefPubMedGoogle Scholar
  • 41 Fujimoto K, Abe T, Müller NL , et al. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis. Radiology 2003; 227 (3) 786-793
    CrossrefPubMedGoogle Scholar
  • 42 Ohno Y, Hatabu H, Takenaka D , et al. Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung. Eur J Radiol 2004; 52 (2) 144-150
    CrossrefPubMedGoogle Scholar
  • 43 Schaefer JF, Vollmar J, Schick F , et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging—perfusion differences in malignant and benign lesions. Radiology 2004; 232 (2) 544-553
    CrossrefPubMedGoogle Scholar
  • 44 Schaefer JF, Schneider V, Vollmar J , et al. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer 2006; 53 (1) 39-49
    CrossrefPubMedGoogle Scholar
  • 45 Kono R, Fujimoto K, Terasaki H , et al. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol 2007; 188 (1) 26-36
    CrossrefPubMedGoogle Scholar
  • 46 Ohno Y, Koyama H, Takenaka D , et al. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging 2008; 27 (6) 1284-1295
    CrossrefPubMedGoogle Scholar
  • 47 Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumors. 7th ed. New York, NY: Wiley-Liss; 2009
    Google Scholar
  • 48 Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer 2000; 28 (3) 187-202
    CrossrefPubMedGoogle Scholar
  • 49 Vansteenkiste JF. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl 2002; 35: 49s-60s
    PubMedGoogle Scholar
  • 50 Ohno Y, Hatabu H, Takenaka D , et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 2004; 231 (3) 872-879
    CrossrefPubMedGoogle Scholar
  • 51 Ohno Y, Koyama H, Nogami M , et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 2007; 26 (4) 1071-1080
    CrossrefPubMedGoogle Scholar
  • 52 Yi CA, Shin KM, Lee KS , et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008; 248 (2) 632-642
    CrossrefPubMedGoogle Scholar
  • 53 Morikawa M, Demura Y, Ishizaki T , et al. The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax. J Nucl Med 2009; 50 (1) 81-87
    PubMedGoogle Scholar
  • 54 Ohno Y, Koyama H, Yoshikawa T , et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology 2011; 261 (2) 605-615
    CrossrefPubMedGoogle Scholar
  • 55 Nomori H, Mori T, Ikeda K , et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008; 135 (4) 816-822
    CrossrefPubMedGoogle Scholar
  • 56 Hasegawa I, Boiselle PM, Kuwabara K, Sawafuji M, Sugiura H. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 2008; 23 (3) 157-161
    CrossrefPubMedGoogle Scholar
  • 57 Pauls S, Schmidt SA, Juchems MS , et al. Diffusion-weighted MR imaging in comparison to integrated [18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 2012; 81 (1) 178-182
    CrossrefPubMedGoogle Scholar
  • 58 Quint LE, Tummala S, Brisson LJ , et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996; 62 (1) 246-250
    CrossrefPubMedGoogle Scholar
  • 59 Pantel K, Izbicki J, Passlick B , et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996; 347 (9002): 649-653
    CrossrefPubMedGoogle Scholar
  • 60 Silvestri GA, Gould MK, Margolis ML , et al; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): S178-S201
    CrossrefPubMedGoogle Scholar
  • 61 Simon GR, Turrisi A ; American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl) S324-S339
    CrossrefPubMedGoogle Scholar
  • 62 Samson DJ, Seidenfeld J, Simon GR , et al; American College of Chest Physicians. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl) S314-S323
    CrossrefPubMedGoogle Scholar
  • 63 Walker R, Kessar P, Blanchard R , et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 2000; 11 (4) 343-350
    CrossrefPubMedGoogle Scholar
  • 64 Antoch G, Vogt FM, Freudenberg LS , et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003; 290 (24) 3199-3206
    CrossrefPubMedGoogle Scholar
  • 65 Lauenstein TC, Goehde SC, Herborn CU , et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004; 233 (1) 139-148
    CrossrefPubMedGoogle Scholar
  • 66 Goehde SC, Hunold P, Vogt FM , et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR Am J Roentgenol 2005; 184 (2) 598-611
    CrossrefPubMedGoogle Scholar
  • 67 Schmidt GP, Haug AR, Schoenberg SO, Reiser MF. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 2006; 16 (6) 1216-1225
    CrossrefPubMedGoogle Scholar
  • 68 Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6: 135-143
    CrossrefPubMedGoogle Scholar
  • 69 Ohno Y, Koyama H, Nogami M , et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007; 26 (3) 498-509
    CrossrefPubMedGoogle Scholar
  • 70 Ohno Y, Koyama H, Onishi Y , et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248 (2) 643-654
    CrossrefPubMedGoogle Scholar
  • 71 Takenaka D, Ohno Y, Matsumoto K , et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30 (2) 298-308
    CrossrefPubMedGoogle Scholar
  • 72 Sommer G, Wiese M, Winter L , et al. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol 2012; 22 (12) 2859-2867
    CrossrefPubMedGoogle Scholar
  • 73 Takahashi K, Al-Janabi NJ. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 2010; 32 (6) 1325-1339
    CrossrefPubMedGoogle Scholar
  • 74 Inaoka T, Takahashi K, Iwata K , et al. Evaluation of normal fatty replacement of the thymus with chemical-shift MR imaging for identification of the normal thymus. J Magn Reson Imaging 2005; 22 (3) 341-346
    CrossrefPubMedGoogle Scholar
  • 75 Linegar AG, Odell JA, Fennell WM , et al. Massive thymic hyperplasia. Ann Thorac Surg 1993; 55 (5) 1197-1201
    CrossrefPubMedGoogle Scholar
  • 76 Takahashi K, Inaoka T, Murakami N , et al. Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging. AJR Am J Roentgenol 2003; 180 (5) 1265-1269
    CrossrefPubMedGoogle Scholar
  • 77 Inaoka T, Takahashi K, Mineta M , et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243 (3) 869-876
    CrossrefPubMedGoogle Scholar
  • 78 Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 2007; 64 (3) 356-366
    CrossrefPubMedGoogle Scholar
  • 79 Falaschi F, Battolla L, Mascalchi M , et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 1996; 166 (4) 963-968
    CrossrefPubMedGoogle Scholar
  • 80 Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353 (15) 1591-1603
    CrossrefPubMedGoogle Scholar
  • 81 Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998; 16 (1) 145-152
    PubMedGoogle Scholar
  • 82 Helm EJ, Matin TN, Gleeson FV. Imaging of the pleura. J Magn Reson Imaging 2010; 32 (6) 1275-1286
    CrossrefPubMedGoogle Scholar
  • 83 Hierholzer J, Luo L, Bittner RC , et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118 (3) 604-609
    CrossrefPubMedGoogle Scholar
  • 84 Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172 (4) 1039-1047
    CrossrefPubMedGoogle Scholar
  • 85 Patz Jr EF, Shaffer K, Piwnica-Worms DR , et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159 (5) 961-966
    CrossrefPubMedGoogle Scholar
  • 86 Sugarbaker DJ, Flores RM, Jaklitsch MT , et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117 (1) 54-63 , discussion 63–65
    CrossrefPubMedGoogle Scholar
  • 87 Gill RR, Umeoka S, Mamata H , et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 2010; 195 (2) W125-30
    PubMedGoogle Scholar
  • 88 Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150 (4) 947-955
    CrossrefPubMedGoogle Scholar
  • 89 Bolliger CT, Jordan P, Solèr M , et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med 1995; 151 (5) 1472-1480
    CrossrefPubMedGoogle Scholar
  • 90 Wyser C, Stulz P, Solèr M , et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 1999; 159 (5 Pt 1) 1450-1456
    CrossrefPubMedGoogle Scholar
  • 91 Mazzone PJ, Arroliga AC. Lung cancer: Preoperative pulmonary evaluation of the lung resection candidate. Am J Med 2005; 118 (6) 578-583
    CrossrefPubMedGoogle Scholar
  • 92 Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT ; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): 161S-177S
    CrossrefPubMedGoogle Scholar
  • 93 Iwasawa T, Saito K, Ogawa N, Ishiwa N, Kurihara H. Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung. J Magn Reson Imaging 2002; 15 (6) 685-692
    CrossrefPubMedGoogle Scholar
  • 94 Ohno Y, Hatabu H, Higashino T , et al. Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. AJR Am J Roentgenol 2004; 182 (1) 73-78
    CrossrefPubMedGoogle Scholar
  • 95 Ohno Y, Koyama H, Nogami M , et al. Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol 2007; 189 (2) 400-408
    CrossrefPubMedGoogle Scholar
  • 96 Ohno Y, Koyama H, Nogami M , et al. State-of-the-art radiological techniques improve the assessment of postoperative lung function in patients with non-small cell lung cancer. Eur J Radiol 2011; 77 (1) 97-104
    CrossrefPubMedGoogle Scholar
  • 97 Ohno Y, Hatabu H, Higashino T , et al. Oxygen-enhanced MR imaging: correlation with postsurgical lung function in patients with lung cancer. Radiology 2005; 236 (2) 704-711
    CrossrefPubMedGoogle Scholar
  • 98 Eisenhauer EA, Therasse P, Bogaerts J , et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45 (2) 228-247
    CrossrefPubMedGoogle Scholar
  • 99 Ohno Y, Nogami M, Higashino T , et al. Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy. J Magn Reson Imaging 2005; 21 (6) 775-783
    CrossrefPubMedGoogle Scholar
  • 100 de Langen AJ, van den Boogaart V, Lubberink M , et al. Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med 2011; 52 (1) 48-55
    CrossrefPubMedGoogle Scholar
  • 101 Giesel FL, Bischoff H, von Tengg-Kobligk H , et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest 2006; 129 (6) 1570-1576
    CrossrefPubMedGoogle Scholar
  • 102 Giesel FL, Choyke PL, Mehndiratta A , et al. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol 2008; 15 (5) 563-570
    CrossrefPubMedGoogle Scholar
  • 103 Yabuuchi H, Hatakenaka M, Takayama K , et al. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology 2011; 261 (2) 598-604
    CrossrefPubMedGoogle Scholar
  • 104 Ohno Y, Koyama H, Yoshikawa T , et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR Am J Roentgenol 2012; 198 (1) 75-82
    CrossrefPubMedGoogle Scholar